Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tabor

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
World Journal of Gastroenterology|September 24, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceMichelle L Boland, Denise Oró, Kirstine S Tølbøl, et al.
Journal of Clinical Microbiology|November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremiaBatu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Npj Antimicrobials and Resistance|May 8, 2026
Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patientsThomas E van der Schalk, Matilda Berkell, An Hottebeekx, et al.
Nature Communications|April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Science (New York, N.Y.)|March 24, 2000
A BAC-based physical map of the major autosomes of Drosophila melanogasterR A Hoskins, C R Nelson, B P Berman, et al.
BMC Infectious Diseases|June 28, 2020
Global molecular diversity of RSV - the "INFORM RSV" studyAnnefleur C Langedijk, Robert Jan Lebbink, Christiana Naaktgeboren, et al.
Genome Biology|January 23, 2003
Finishing a whole-genome shotgun: release 3 of the Drosophila melanogaster euchromatic genome sequenceSusan E Celniker, David A Wheeler, Brent Kronmiller, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
The Lancet. Infectious Diseases|March 20, 2023
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing dataDeidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
World Journal of Gastroenterology|September 24, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceMichelle L Boland, Denise Oró, Kirstine S Tølbøl, et al.
Journal of Clinical Microbiology|November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremiaBatu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Npj Antimicrobials and Resistance|May 8, 2026
Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patientsThomas E van der Schalk, Matilda Berkell, An Hottebeekx, et al.
Nature Communications|April 8, 2024
Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Nature Communications|July 19, 2023
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsBahar Ahani, Kevin M Tuffy, Anastasia A Aksyuk, et al.
Science (New York, N.Y.)|March 24, 2000
A BAC-based physical map of the major autosomes of Drosophila melanogasterR A Hoskins, C R Nelson, B P Berman, et al.
BMC Infectious Diseases|June 28, 2020
Global molecular diversity of RSV - the "INFORM RSV" studyAnnefleur C Langedijk, Robert Jan Lebbink, Christiana Naaktgeboren, et al.
Genome Biology|January 23, 2003
Finishing a whole-genome shotgun: release 3 of the Drosophila melanogaster euchromatic genome sequenceSusan E Celniker, David A Wheeler, Brent Kronmiller, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
The Lancet. Infectious Diseases|March 20, 2023
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing dataDeidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink, et al.
Pageof 27